Linda Rhodes - 21 May 2024 Form 4 Insider Report for Zoetis Inc. (ZTS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
22 May 2024, 16:52:01 UTC
Prior SEC filing
13 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brenda Santuccio, as Attorney-in-Fact

Key filing fact

Linda Rhodes filed Form 4 for Zoetis Inc. (ZTS) on 22 May 2024.

Key facts

  • This page summarizes Linda Rhodes's Form 4 filing for Zoetis Inc. (ZTS).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 22 May 2024, 16:52.

Change

  • Previous filing in this sequence was filed on 13 Feb 2024.
  • Current net transaction value: -$93,479.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZTS transaction

Common Stock

Options Exercise

Transaction value
Shares
+2,441
Change %
+26%
Price
Shares after
11,733
Date
21 May 2024
Ownership
Direct
Footnotes
F1
ZTS transaction

Common Stock

Other

Transaction value
$93,479
Shares
-541
Change %
-4.6%
Price
$172.79
Shares after
11,192
Date
21 May 2024
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZTS transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-1,216
Change %
-100%
Price
$0.000000*
Shares after
0
Date
21 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,216
Exercise price
Footnotes
F3, F4, F5, F6
ZTS transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-1,227
Change %
-100%
Price
$0.000000*
Shares after
0
Date
21 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,227
Exercise price
Footnotes
F4, F6, F7, F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Linda Rhodes is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 8 footnotes

Footnote F1

Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs) in connection with Dr. Rhodes' retirement from the Zoetis Board of Directors.

Footnote F2

Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date.

Footnote F3

Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

Footnote F4

Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

Footnote F5

Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, February 8, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F6

Not applicable.

Footnote F7

Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

Footnote F8

Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .